Daniel Park

Nessuna posizione attualmente

Health Technology

Consumer Services

Producer Manufacturing

Profilo

Daniel S.
Park served as the Executive Vice President at ILJIN Holdings Co., Ltd.
and as the Non-Executive Director & Chief Business Officer at Isotechnika Pharma, Inc. in 2012.
He also served as an Independent Director at Aurinia Pharmaceuticals, Inc. Mr. Park holds an MBA from the University of California, Los Angeles and completed his undergraduate and graduate studies at Seoul National University.

Precedenti posizioni note di Daniel Park

Società	Posizione	Fine
Isotechnika Pharma, Inc. Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada.	Direttore/Membro del Consiglio	28/06/2012
AURINIA PHARMACEUTICALS INC.	Direttore/Membro del Consiglio	-
ILJIN HOLDINGS CO.,LTD.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Daniel Park

Formazione di Daniel Park

University of California, Los Angeles	Masters Business Admin
Seoul National University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private